Background
Five pharmacists operating five pharmacies in Michigan and Ohio engaged in a scheme to bill insurers for prescriptions they did not dispense. They targeted patients who did not pick up medications, forged signatures, and replaced brand-name drugs with generics to pocket insurance payments. Qlarant, a contractor for the federal government, detected the fraud by comparing wholesaler invoices to billing records, calculating a loss of over thirteen million dollars. Four defendants went to trial and were convicted of conspiracy to commit healthcare and wire fraud, with one defendant also convicted of substantive healthcare fraud.
The court’s reasoning
The court held that the expert witness, Johanna Sullivan, did not violate the Confrontation Clause because she performed her own analysis and quality check on the data rather than merely acting as a mouthpiece for non-testifying analysts. The district court properly excluded evidence of legitimate billing and PBM bias as irrelevant or confusing under Rule four zero three. The court found no plain error in the district court referring to Sullivan as an expert, noting that jury instructions mitigated any prejudice. The evidence supported a single conspiracy charge due to a common goal of profit, identical methods, and overlapping participants. The district court did not abuse its discretion in denying a subpoena for wholesaler records or in refusing to poll the jury based on a juror’s letter.
What it means going forward
The decision reinforces the admissibility of expert testimony based on data processed by teams, provided the testifying expert performs an independent assessment. It clarifies that defendants cannot introduce evidence of legitimate business operations to negate specific charges of fraud and confirms that overlapping operations can constitute a single conspiracy.